By Mehr Sokhanda
Venturing into the world of angel investing can be both thrilling and daunting. The promise of being part of the next big innovation is exciting—but without the right knowledge, it’s also risky. If you’re new to the startup world and considering writing your first cheque, this guide is for you.
Alexander Morsink—angel investor and Managing Director of Equivesto— breaks down everything a first-time investor should know before structuring their first deal. From understanding what type of business to invest in, to choosing the right investment structure and preparing for dilution, it serves as a practical crash course in early-stage startup investing.
Who Gets to Invest?
The legal and financial frameworks around private investing in Canada are tightly regulated. Morsink outlines three main investor categories. The first is the Accredited Investor, which includes individuals earning over $200,000 annually (or $300,000 with a spouse) or holding over $1 million in net financial assets (excluding real estate). These investors face no maximum investment limits and are able to participate in any private deal, including early-stage startup rounds.
For those who don’t meet accredited thresholds, Equity Crowdfunding provides a more accessible route. Through regulated platforms like Equivesto, any Canadian can invest up to $10,000 per deal, with added protections and disclosure requirements. There’s also a newer category, the Self-Certified Investor, which exists in some provinces and allows individuals with professional or academic experience in finance or investing to invest up to $30,000 per year.
These distinctions matter because the type of investor you are determines the deals you can access and the limits you must follow. “Different legal avenues to invest into private Canadian businesses,” Morsink notes, “are regulated by Canadian Securities Regulators. The pathways for investing are set based on your personal income and Net Financial Assets.”
Timing Your Entry: Where Angels Fit In
Knowing when to invest in a startup is just as critical as knowing what to invest in. According to Morsink, angel investors typically participate at the pre-seed or seed stages of a startup’s lifecycle. These are moments when the startup has developed a beta version or minimum viable product (MVP), is beginning to find product-market fit, and needs capital to build traction.
The pre-seed stage typically involves valuations under $3 million, and raises under $1 million. The seed stage follows with valuations ranging from $3–10 million and funding rounds of $1–3 million. These early rounds can be vital for startup survival and provide entry points for angels looking to capitalize on future growth.
Morsink maps out the capital raise lifecycle clearly: “Angel Investors typically enter at Pre-Seed and Seed… Companies are valued between $3M and $10M and often invest via SAFE, Convertible Note (recommended), or equity (priced round).” These early-stage investments carry significant risk, but they also offer the highest potential for returns due to the lower valuation entry point.
Understanding Startup Stages and Valuation Growth
Startups tend to follow a predictable trajectory that aligns with their funding and valuation milestones. Morsink outlines four key stages:
- Pre-Seed (The Beta Stage): At this point, the company may only have a prototype or early version of its product. Valuations are typically under $3 million, with raises below $1 million.
- Seed (The MVP Stage): The startup has a minimum viable product and initial traction. Valuations range from $3–10 million, and raise amounts fall between $1–3 million.
- Series A (The Product-Market Fit Stage): With demonstrated traction, startups now seek to scale. Valuations increase to $10–20 million, with raises from $2–7 million.
- Series B+ (The Scaling Stage): At this point, the business is focused on growth and expansion. Valuations exceed $20 million, and raise sizes exceed $7 million.
For first-time investors, the Pre-Seed and Seed stages are the most accessible—and potentially the most rewarding—entry points. If the startup successfully reaches Series B or beyond, early investments can multiply significantly in value.
Where Angel Investors Fit in the Funding Journey
Morsink also illustrates the typical Capital Raise Lifecycle of a startup, which helps clarify where different types of investors enter. It begins with bootstrapping or support from friends and family during the ideation stage. From there:
- Pre-Seed: Often supported by friends, family, and some angels
- Seed: Where most angel investors and early-stage equity crowdfunding participants come in
- Series A and B: At this stage, venture capital firms begin to dominate
- Series C and beyond: This is typically where private equity firms and large institutional investors enter
Understanding this lifecycle helps new investors see how their capital fits into the broader funding roadmap—and what kinds of investors will eventually follow their lead.
Why Startups, Not Small Businesses?
Before diving into valuation techniques, it’s important to understand what’s actually being valued. Small businesses and startups are not evaluated the same way, because they’re fundamentally different investment opportunities. As Morsink outlines, small businesses are typically valued based on either assets or revenue multiples—for example, “Assets – Liabilities = Value” or “2–3 times annual revenues.”
Startups, on the other hand, are valued based on future potential, not current financials. These companies often have little revenue and minimal assets early on, but aim to grow rapidly. Their valuations are determined by tools like discounted cash flow, comparable company analysis, or projected market size. “Startups are valued based on future potential & company stage,” Morsink notes—making them more volatile but also more lucrative.
This key distinction helps explain why investors with a higher risk tolerance are drawn to startups: the upside potential is significantly larger
Understanding Valuations
Valuing a startup is an exercise in estimating future potential, not measuring current assets. Unlike small businesses, where value can be derived from existing revenue or physical assets, startups often have little more than an idea, a product prototype, and a plan. Valuations are thus based on comparable startups, future projections, and investor sentiment.
One term that often causes confusion is the valuation cap, especially in the context of SAFEs (Simple Agreements for Future Equity) and convertible notes. Morsink clarifies that the cap is not the company’s current valuation but the maximum price at which your investment will convert into equity during a future funding round. “Valuation of a company is not the same as its valuation cap,” he explains. “Valuation cap is essentially a valuation target the company will want to hit or surpass at their subsequent round.”
For first-time investors, it’s crucial to not fixate on valuation alone. What matters more is the startup’s traction, the team’s competence, and whether the cap is realistically achievable within the next 12–24 months.
Choosing the Right Investment Structure
One of the most critical choices you’ll make as an investor is the type of instrument you use to structure your investment. Morsink breaks these down into three main options:
- SAFE,
- Convertible Note, and
- Equity (Common or Preferred Shares).
SAFEs are the simplest—you’re giving the startup money now in exchange for discounted shares in a future round. They are popular in the U.S. but are “the least safe method for investors,” according to Morsink. They lack a maturity date or repayment obligation, so if no future round occurs, the investor remains in limbo—neither a shareholder nor a debt holder.
Convertible notes offer more protection. They function as loans that convert into equity during a future raise. They often include an interest rate and a maturity date, giving investors more leverage if the startup doesn’t raise a follow-up round in a timely manner. “Convertible Notes typically have a maturity date,” Morsink explains, “which SAFEs do not… [It’s the] date at which the company must repay loan and interest (or a renegotiation with investors most likely).”
Finally, priced equity rounds grant immediate shares—either common or preferred—based on an agreed valuation. While more complex and paperwork-heavy, they provide voting rights and actual ownership upfront. For early-stage rounds, convertible notes are often the sweet spot—blending investor security with startup flexibility.
Don’t Be the Reason a Startup Becomes “Uninvestable”
One of the most valuable lessons in Morsink’s presentation is the importance of playing the long game. It’s tempting for new investors to push for protective clauses—anti-dilution rights, board vetoes, preferred shares—but these demands can backfire.
“Pushing for non-standard terms that protect your investment in the short term, can severely impact a company’s ability to successfully raise capital in the future,” he warns. Venture capital firms and institutional investors may walk away from startups burdened by inflexible early investor terms.
Instead, investors should understand and embrace dilution as a natural part of the startup journey. If your early 10% stake eventually dilutes to 2%—but the company grows 100-fold—your upside is still enormous. Focus on enabling long-term success rather than maximizing short-term leverage.
Overall, angel investing is not a game of guarantees. It’s a practice built on educated risk, trust in founders, and long-term vision. As Morsink makes clear, successful investors are those who understand the difference between a bakery and a biotech startup, who know when and how to enter a deal, and who choose structures that protect their investment while still empowering the company to grow.
Brampton Angels is actively seeking new investors who are passionate about supporting early-stage founders. If you’re interested in joining our community of angel investors and driving innovation in Canada’s startup ecosystem, visit us HERE to learn more about becoming a member.
